Fact CheckerSign in

NCT07816627Completed

Applied Conversion Equation for Optical Coherence Tomography

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

The investigator wants to investigate how big the differences are between measurements of the back of the eye taken by different OCT machines. The study is called: Applied Conversion Equation for Optical Coherence Tomography (ACE-OCT) study.

Status (registry)
Completed
Study type
Observational
Enrollment
338 (actual)
First submitted
2 Jun 2026
Start date
3 Mar 2024
Primary completion date
31 Oct 2025
Lead sponsor
Gloucestershire Hospitals NHS Foundation Trust
NCT number
NCT07816627

What you commit to

  • Study type: Observational
  • Participants enrolled: 338
  • From 3 Mar 2024 to the primary completion date, 31 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Patients under 18 years old
  • People with other ocular pathologies known to impact retinal thickness, including:
    • Age related Macular Degeneration (AMD)
    • Branch or central retinal vein occlusion (BRVO/CRVO)
    • Macular Hole
    • Glaucoma
    • High Myopia with a spherical equivalent \> -5.00 diopters
    • Epiretinal membrane

Other

  • People unwilling or unable to give informed consent
  • Patients in whom it is not possible to take OCT scans, for instance those with:
    • Dense cataracts
    • Corneal Scarring
    • Severe physical disabilities preventing them from adequate positioning.
  • Eyes with at least one scan containing segmentation errors
  • Eyes with at least one scan that is ungradable

Who the study is looking for

  • Patients aged 18 years or above
  • Patients with a diagnosis of Type 1 or Type 2 Diabetes Mellitus
  • Patients with a known diagnosis of DMO in at least one eye
  • Patients being seen in DMO clinics, Digital Surveillance Clinic or Virtual Diabetic Retinopathy clinics

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gloucestershire Hospitals NHS Foundation Trust
Coordinator of this site? Confirm its status
GloucesterUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.